RoxyBond™ (oxycodone) – New drug approval
April 26, 2017 – Inspirion Delivery Sciences announced the FDA approval of RoxyBond (oxycodone) for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
Download PDF
